Rounds: A message from the President and CEO of VUMC

I write to thank you for your incredible dedication to our missions, for so many wonderful accomplishments in 2016 and to share some aspirations for 2017 and beyond.

Fire and smoke-related injuries on the rise this winter

Vanderbilt emergency medicine physician offers tips for a safe New Year’s celebration

Investigational new drug for Alzheimer’s scheduled for first study in humans

Vanderbilt University scientists have received notification from the U.S. Food and Drug Administration that testing in humans may proceed for an investigational new drug for Alzheimer’s disease after more than 10 years of research by scientists at Vanderbilt University and Vanderbilt University Medical Center.

Discovery sheds new light on Angelman, Prader-Willi syndromes

A mutation associated with epilepsy and autism also is responsible for a “pale eye” trait in two rare genetic disorders, Angelman syndrome and Prader-Willi syndrome, neuroscientists at Vanderbilt University Medical Center reported this week.

Daughter’s rare adverse drug reaction inspires family’s donation

Last year Paul and Wanpen Anderson of Champaign, Illinois, were preparing to celebrate the Christmas holidays with their two children when their 22-year-old daughter, Angela, developed a rare adverse drug reaction called SJS/TEN.